Gelonghui, May 8, 丨 Shenlian Biology (688098.SH) said on the interactive platform that the company has now accumulated synthetic biotechnology based on yeast strains, etc., and related platforms are in the process of development and construction, and no related products have yet been produced.
申联生物(688098.SH)：目前已有基于酵母菌株等方面的合成生物技术积累
Shenlian Biology (688098.SH): At present, it has accumulated synthetic biotechnology based on yeast strains, etc.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.